Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan + amoxicillin + doxycycline vs bismuth quadruple therapy for first-line Helicobacter pylori eradication
ChiCTR2300075084Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Ningbo University
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of vonoprazan in Helicobacter pylori infection (2 arms), sponsored by First Affiliated Hospital of Ningbo University. Primary endpoint: Eradication rates of Helicobacter pylori. Started Aug 2023; status: recruiting.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2300075084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300075084.